Moreover, the regulation of MSN phosphorylation is controlled by Rho-associated protein kinases (ROCK) [80], and specific ROCK inhibitors (e.g., Netarsudil), in turn, were currently launched as promising glaucoma medications [81]. The gene discussed is MSN; the disease is glaucoma.